InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-0.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bradway Robert A, Chief Executive Officer. Officer active across 1 company, notably AMGEN INC. In total, 31 reports have been published. Activity tracked since 30 April 2021. The latest transaction was disclosed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations31 total
2,631 shares@ US$329.820.0004% mcap3.3% of flowCommon StockSEC:0000318154-26-000058:0
2,426 shares@ US$329.820.0004% mcap3.0% of flowCommon StockSEC:0000318154-26-000058:1
13,311 shares0Common StockSEC:0001127602-25-013788:0
2,352 shares@ US$283.782.6% of flowCommon StockSEC:0001127602-25-013525:1
2,481 shares@ US$283.782.7% of flowCommon StockSEC:0001127602-25-013525:0
2,544 shares@ US$288.562.9% of flowCommon StockSEC:0001127602-25-013278:0
12,853 shares@ US$313.7116.3% of flowCommon StockSEC:0001127602-25-010053:0
25,734 shares0Common StockSEC:0001127602-25-008420:0
96,000 shares0Common StockSEC:0001127602-24-028560:0
90,000 shares0Common StockSEC:0001127602-24-028560:1
90,000 shares0Common StockSEC:0001127602-24-028560:2
11,988 shares0Common StockSEC:0001127602-24-014847:0
2,220 shares@ US$311.292.8% of flowCommon StockSEC:0001127602-24-014504:0
2,294 shares@ US$277.372.6% of flowCommon StockSEC:0001127602-24-014350:0
2,282 shares@ US$276.382.6% of flowCommon StockSEC:0001127602-24-013809:0
20,560 shares@ US$268.8722.4% of flowCommon StockSEC:0001127602-24-010846:0
41,133 shares0Common StockSEC:0001127602-24-009236:0
2,083 shares@ US$231.891.9% of flowCommon StockSEC:0001127602-23-015043:0
13,486 shares0Common StockSEC:0001127602-23-014605:0
2,208 shares@ US$239.742.1% of flowCommon StockSEC:0001127602-23-014149:0
13,971 shares@ US$234.5713.6% of flowCommon StockSEC:0001127602-23-010906:0
27,915 shares0Common StockSEC:0001127602-23-009505:0
2,017 shares@ US$236.100.0003% mcap9.5% of flowCommon StockSEC:0001127602-22-013868:0
13,781 shares0Common StockSEC:0001127602-22-013339:0
2,547 shares@ US$249.870.0003% mcap12.6% of flowCommon StockSEC:0001127602-22-012758:0
25 of 31 declarations
About Bradway Robert A
Robert A. Bradway is Chairman, CEO, and President of Amgen Inc. He is responsible for the strategic and operational leadership of the company. With extensive experience in the biopharmaceutical sector, he plays a key role in decision-making that influences the company's performance and growth.
